NDC 50242-136-01
ACTEMRA 200 mg/10mL
tocilizumab · INJECTION, SOLUTION, CONCENTRATE
ACTEMRA is a injection, solution, concentrate containing tocilizumab at a strength of 200 mg/10mL. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- ACTEMRA
- Generic Name
- tocilizumab
- NDC Code (Package)
50242-136-01- NDC Code (Product)
50242-136- Manufacturer
- Genentech, Inc.
- Strength
- 200 mg/10mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125276
- Drug Class
- Interleukin-6 Receptor Antagonist [EPC]
- Marketing Start
- 01/08/2010
Recall History
No Recall HistoryView Full Drug Page
ACTEMRA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.